Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-018492

Options or other derivatives

  • General Counsel and Secretary acquired 43,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2020-03-10 Grant or award · Stock Option (Right to Buy) +35,000 35,000 D
KASINGER JAMES R. General Counsel and Secretary 2020-03-10 Grant or award · Restricted Stock Units +8,500 8,500 D
Loading xslF345X03/doc4.xml…